Dr. Gregory Shipley, talks about how he goes about evaluating and investing in new technologies and reagents for carrying out real-time quantitative polymerase chain reactions (qPCR) for the various assays being conducted in his core facility.
Run a Search
We’ve updated our Privacy Policy to make it clearer how we use your personal data.
Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.